文献速递胃肠外科

机器人对比腹腔镜微创手术治疗直肠癌:随机对照试验的系统评价与Meta分析

Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Ann Surg · 2018-01-01

该系统评价与Meta分析纳入5项随机对照试验,共334例机器人手术和337例腹腔镜手术病例,比较两种术式治疗直肠癌的安全性与有效性。结果显示机器人手术中转开腹率更低(7.3%,RR 0.58,95%CI 0.35-0.97,P=0.04),但手术时间更长(MD 38.43分钟,95%CI 31.84-45.01,P<0.00001);环周切缘阳性率、淋巴结清扫数目及围术期死亡率两组相似。证据质量多为中等,支持机器人手术围术期肿瘤学 adequacy 与腹腔镜相当。

要点

  • 机器人直肠癌手术中转开腹率显著低于腹腔镜(RR 0.58,95%CI 0.35-0.97)。
  • 机器人手术时间较腹腔镜延长约38分钟(MD 38.43,95%CI 31.84-45.01)。
  • 环周切缘阳性率、淋巴结清扫数与围术期死亡率两组无显著差异。

核心结论

  • 中等质量证据支持机器人直肠癌手术的围术期肿瘤学结局与腹腔镜手术相似。
  • 机器人手术中转开腹率更低,但手术时间显著更长。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、Embase和CENTRAL截至2016年8月的随机对照试验。
  • 纳入5项随机对照试验,共334例机器人手术和337例腹腔镜手术病例。

主要发现

  • 机器人手术中转开腹率为7.3%(4项研究,544例参与者,RR 0.58,95%CI 0.35-0.97,P=0.04,I=0%)。
  • 机器人手术时间较腹腔镜延长38.43分钟(95%CI 31.84-45.01,P<0.00001)。
  • 环周切缘阳性率两组相似(2项研究,489例参与者,RR 0.82,95%CI 0.39-1.73)。
  • 淋巴结清扫数目两组相似(平均17.4枚,5项试验,674例患者,MD -0.35,95%CI -1.83至1.12)。
  • 围术期死亡率两组相似。

关键数值与推荐

  • 机器人手术中转开腹率7.3%,显著低于腹腔镜(RR 0.58,95%CI 0.35-0.97,P=0.04)。
  • 机器人手术时间显著长于腹腔镜(MD 38.43分钟,95%CI 31.84-45.01,P<0.00001)。
  • 环周切缘阳性率无显著差异(RR 0.82,95%CI 0.39-1.73)。
  • 淋巴结清扫数目无显著差异(MD -0.35,95%CI -1.83至1.12)。

临床怎么用

  • 机器人直肠癌手术可作为腹腔镜手术的替代选择,围术期肿瘤学结局相似。
  • 对于预期中转开腹风险较高的病例,机器人手术可能降低中转率。
  • 需权衡机器人手术较长手术时间带来的资源与麻醉影响。

局限性

  • 纳入试验数量较少(5项),部分结局证据质量仅为中等。
  • 检索截止至2016年8月,未纳入此后发表的新证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the safety and efficacy of elective rectal resection for rectal cancer in adults by robotic surgery compared with conventional laparoscopic surgery. SUMMARY OF BACKGROUND DATA: Technological advantages of robotic surgery favor precise dissection in narrow spaces. However, the evidence base driving recommendations for the use of robotic surgery in rectal cancer primarily hinges on observational data. METHODS: We searched MEDLINE, Embase, and CENTRAL for randomized controlled trials (until August 2016) comparing robotic surgery versus conventional laparoscopic surgery. Data on the following endpoints were evaluated: circumferential margin status, mesorectal grade, number of lymph nodes harvested, rate of conversion to open surgery, postoperative complications, and operative time. Data were summarized as relative risks (RR) or weighted mean differences (WMDs) with 95% confidence intervals (95% CIs). Risk of bias of studies was assessed with standard methods. RESULTS: Five trials were eligible, including 334 robotic and 337 laparoscopic surgery cases. Meta-analysis showed that RS was associated with lower conversion rate (7.3%; 4 studies, 544 participants, RR 0.58; 95% CI 0.35-0.97, P = 0.04, I = 0%) and longer operating time (MD 38.43 minutes, 95% CI 31.84-45.01: P < 0.00001) compared with laparoscopic surgery. Perioperative mortality, rate of circumferential margin involvement (2 studies, 489 participants, RR 0.82, 95% CI 0.39-1.73), and lymph nodes collected (mean 17.4 Lymph Nodes; 5 trials, 674 patients, MD -0.35, 95% CI -1.83 to 1.12) were similar. The quality of the evidence was moderate for most outcomes. CONCLUSION: Evidence of moderate quality supports that robotic surgery for rectal cancer produces similar perioperative outcomes of oncologic procedure adequacy to conventional laparoscopic surgery. Robotic surgery portraits lower rate of conversion to open surgery, while operating time is significantly longer than by laparoscopic approach.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Prete FP, Pezzolla A, Prete F, et al. Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Surg. 2018. PMID: 28984644. doi:10.1097/SLA.0000000000002523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。